US Patent Issued to Valo Health on March 18 for "Inhibiting deubiquitinase USP25 and USP28" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,490, issued on March 18, was assigned to Valo Health Inc. (Lexington, Mass.).

"Inhibiting deubiquitinase USP25 and USP28" was invented by David J. Guerin (Natick, Mass.), Justin A. Caravella (Cambridge, Mass.), Hongbin Li (Madison, Conn.), Steven Mischke (Waltham, Mass.), David J. Richard (Littleton, Mass.), Shawn E. R. Schiller (Haverhill, Mass.) and Tatiana Shelekhin (Ridgefield, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The mod...